Shenyang Xingqi Pharmaceutical Co.,Ltd. (SHE:300573)

SHE:300573 Revenue

Shenyang Xingqi Pharmaceutical had revenue of 717.54M CNY in the quarter ending June 30, 2026, with 14.51% growth. This brings the company's total for the last twelve months to 2.71B, up 22.43% year-over-year. In the year 2025, Shenyang Xingqi Pharmaceutical had annual revenue of 2.47B with 27.24% growth. That makes Shenyang Xingqi Pharmaceutical the 12,463rd largest company in the world by revenue and 2,150th in China.

• Revenue (ttm): 2.71B
• Revenue Growth: +22.43%
• P/S Ratio: 4.35
• Revenue / Employee: 1.13M
• Employees: 2,396
• Market Cap: 11.80B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Pharmaceutical Manufacturing 2.39B 96.5%
• Medical Service 66.10M 2.7%
• Unallocated Other Operations 19.92M 0.8%

Fiscal year ended Dec 31, 2025 See the full SHE:300573 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.47B	529.46M	27.24%
Dec 31, 2024	1.94B	475.82M	32.42%
Dec 31, 2023	1.47B	217.71M	17.42%
Jan 1, 2023	1.25B	221.94M	21.59%
Jan 1, 2022	1.03B	339.23M	49.26%

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 24, 2026

Data Sources Report a data error